Key facts
- This page summarizes BURGESS ERNEST G III's Form 4 filing for NATIONAL HEALTHCARE CORP (NHC).
- 1 reported transaction and 5 derivative rows are listed below.
- Accepted by SEC: 13 May 2024, 17:27.
BURGESS ERNEST G III - 09 May 2024 Form 4 Insider Report for NATIONAL HEALTHCARE CORP (NHC)
- Reporting relationship
- Director
- Issuer ticker
- NHC
- Reported as of
- 09 May 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 13 May 2024, 17:27:35 UTC
- Prior SEC filing
- 03 May 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Ernest G. Burgess, III
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
BURGESS ERNEST G III filed Form 4 for NATIONAL HEALTHCARE CORP (NHC) on 13 May 2024.
Change
- Previous filing in this sequence was filed on 03 May 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NHC
holding
Shares of Common Stock held in BTCP Trust
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 86,150
- Date
- 09 May 2024
- Ownership
- Trustee
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
NHC
transaction
Derivative
Option to Purchase Common Stock [2024 Grant]
Award
- Transaction value
- $0
- Shares
- +7,500
- Change %
- Price
- $0.000000
- Shares after
- 7,500
- Date
- 09 May 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,500
- Exercise price
- $96.03
- Footnotes
- F1
NHC
holding
Derivative
Option to Purchase Common Stock [2020 Grant]
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 5,500
- Date
- 09 May 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 5,500
- Exercise price
- $64.64
NHC
holding
Derivative
Option to Purchase Common Stock [2021 Grant]
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 7,500
- Date
- 09 May 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,500
- Exercise price
- $71.64
NHC
holding
Derivative
Option to Purchase Common Stock [2022 Grant]
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 7,500
- Date
- 09 May 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,500
- Exercise price
- $69.19
NHC
holding
Derivative
Option to Purchase Common Stock [2023 Grant]
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 7,500
- Date
- 09 May 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,500
- Exercise price
- $55.75
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 9, 2024. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).